KNSA (Kiniksa Pharmaceuticals) Pangali Forward P/E

Logo korporat perusahaan Kiniksa Pharmaceuticals Ltd (KNSA)

Kiniksa Pharmaceuticals focuses on developing drugs for the treatment of rare immune and cardiovascular pathologies, avoiding the mass market. The GURU.Markets terminal displays the company's forward P/E ratio, where the value 47.50 indicates the valuation status. The business implements targeted methods to combat autoinflammation, creating a closed ecosystem for patients with pericarditis under strict FDA control.

Prakiraan rega marang bathi: Kiniksa (KNSA) kanggo 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Kiniksa Pharmaceuticals

Ringkesan analitik perusahaan:kiniksa.com
Sampel barang Kiniksa Pharmaceuticals

Investors are verifying the asset's long-term sustainability by comparing current market capitalization with expected net income to assess the premium paid for future growth. By analyzing the forward P/E ratio of Kiniksa Pharmaceuticals (KNSA), one can determine the extent to which the market is willing to award a premium for its closed ecosystem for treating rare pathologies, where integration with clinics guarantees a stable cash flow and mitigates patient attrition risks.

Pesaing Kiniksa Pharmaceuticals (KNSA)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Grifols Biemat (GRFS) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Adaptive Biotechnologies|Prakiraan rega marang bathi CLDX|Pangali Forward P/E auriniapharma.com|Rega marang bathi mangsa ngarep BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E DNTH (dianthustx.com)|Pharvaris Pharma (PHVS) - Rasio prakiraan rega marang bathi|AbCellera Biologics - Pangali Forward P/E|tourmalinebio.com - Rasio kapitalisasi marang bathi mangsa ngarep|Precigen (PGEN) - Rega marang bathi mangsa ngarep|Pharming Group - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Nektar Therapeutics Inc|UPB (Upstream Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ZBIO|Pangali Forward P/E immunome.com (IMNM)|Pangali Forward P/E GOSS (gossamerbio.com)|Kapitalisasi marang proyeksi bathi KalVista Pharma (KALV)|SEPN - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Pangali Forward P/E|ATXS (Astria Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Aerovate Therapeutics - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi